We are live on ! Find out more
VA

Vident Advisory Portfolio holdings

AUM $11.7B
1-Year Est. Return 37.32%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+37.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.62B
AUM Growth
-$1.18B
Cap. Flow
-$1.18B
Cap. Flow %
-32.7%
Top 10 Hldgs %
16.49%
Holding
1,533
New
211
Increased
794
Reduced
387
Closed
126

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$52.4M
2
JNJ icon
Johnson & Johnson
JNJ
+$39.1M
3
TMUS icon
T-Mobile US
TMUS
+$37.2M
4
ABBV icon
AbbVie
ABBV
+$35.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34.6M

Sector Composition

Rank Sector Weight
1 Technology 29.28%
2 Financials 10.77%
3 Consumer Discretionary 8.99%
4 Industrials 8.73%
5 Healthcare 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CACI icon
126
CACI
CACI
$10.8B
$5.44M 0.15%
12,654
+3,080
+32% +$1.26M
FICO icon
127
Fair Isaac
FICO
$28.7B
$5.44M 0.15%
3,651
-104
-3% -$134K
ATKR icon
128
Atkore
ATKR
$2.59B
$5.43M 0.15%
40,247
+6,147
+18% +$979K
NKE icon
129
Nike
NKE
$61.9B
$5.42M 0.15%
71,858
-15,475
-18% -$1.44M
ITW icon
130
Illinois Tool Works
ITW
$81.4B
$5.41M 0.15%
22,847
+891
+4% +$220K
FCPT icon
131
Four Corners Property Trust
FCPT
$2.86B
$5.33M 0.15%
216,006
+16,644
+8% +$401K
DHR icon
132
Danaher
DHR
$135B
$5.27M 0.15%
21,079
-2,707
-11% -$684K
ABT icon
133
Abbott
ABT
$180B
$5.25M 0.14%
50,489
+25,823
+105% +$2.74M
TSN icon
134
Tyson Foods
TSN
$20.2B
$5.22M 0.14%
91,288
+75,901
+493% +$4.44M
CI icon
135
Cigna
CI
$76.6B
$5.2M 0.14%
15,742
-77,829
-83% -$26.8M
EQR icon
136
Equity Residential
EQR
$25.4B
$5.2M 0.14%
75,017
+2,389
+3% +$155K
WIT icon
137
Wipro
WIT
$18.5B
$5.2M 0.14%
1,704,228
+1,005,522
+144% +$2.77M
EMR icon
138
Emerson Electric
EMR
$82.9B
$5.18M 0.14%
47,017
+36,212
+335% +$4M
VRSK icon
139
Verisk Analytics
VRSK
$26.4B
$5.16M 0.14%
19,145
+775
+4% +$190K
NVO
140
Novo Nordisk
NVO
$216B
$5.13M 0.14%
35,967
+4,445
+14% +$589K
PHYS icon
141
Sprott Physical Gold
PHYS
$14.6B
$5.12M 0.14%
283,733
+186,812
+193% +$3.39M
WFC icon
142
Wells Fargo
WFC
$261B
$4.99M 0.14%
84,075
+47,128
+128% +$2.78M
IDXX icon
143
Idexx Laboratories
IDXX
$42.9B
$4.96M 0.14%
10,173
+402
+4% +$202K
CLS icon
144
Celestica
CLS
$35.1B
$4.91M 0.14%
85,780
-1,310
-2% -$66.1K
DON icon
145
WisdomTree US MidCap Dividend Fund
DON
$4.03B
$4.81M 0.13%
102,856
+51,428
+100% +$2.43M
GWW icon
146
W.W. Grainger
GWW
$65.3B
$4.78M 0.13%
5,302
-4,395
-45% -$4.13M
ORCL icon
147
Oracle
ORCL
$331B
$4.78M 0.13%
33,838
+1,554
+5% +$193K
COR icon
148
Cencora
COR
$60.3B
$4.77M 0.13%
21,174
+17,497
+476% +$4.05M
CW icon
149
Curtiss-Wright
CW
$27.7B
$4.71M 0.13%
17,386
+5,567
+47% +$1.49M
CSX icon
150
CSX Corp
CSX
$98.6B
$4.68M 0.13%
139,845
+66,335
+90% +$2.25M

Similar funds

Vident Advisory's Q2 2024 Portfolio in Review

As of Q2 2024, Vident Advisory held 1,533 positions worth $3.62B, down 25% from $4.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Advisory withdrew a net $1.18B in Q2 2024, closing 126 positions and reducing 387 holdings. Its most notable exit was Enterprise Products Partners, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Vident Advisory opened a new position in Vanguard Intermediate-Term Treasury ETF worth $19M.

  • Vident Advisory's largest Q2 2024 buy was Vanguard Intermediate-Term Treasury ETF: 326,646 shares worth $19M.
  • Vident Advisory added most to Tesla in Q2 2024, an estimated $29.1M increase.
  • Vident Advisory's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $52.4M.
  • Vident Advisory fully exited Enterprise Products Partners in Q2 2024, selling an estimated $20M.
  • Vident Advisory's ten largest holdings make up 16% of its $3.62B portfolio in Q2 2024.
  • Vident Advisory opened 211 new positions and closed 126 in Q2 2024.
  • Vident Advisory's portfolio value fell 25% quarter-over-quarter to $3.62B.

Based on Vident Advisory's 13F filing for Q2 2024, filed 14 Aug 2024.